novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Non pharmacological options for the management of dyslipidemias

13 Julho 2013

Alberico Catapano

RESUMO DA APRESENTAÇÃO

APRESENTAÇÃO

Parte 1

Parte 2

Faça aqui o download da apresentação completa

Patent foramen ovale. To close or not to close

13 Julho 2013
0

Stent for life. Proud to be Portuguese

13 Julho 2013
0